Advertisement
Screener

DYNAVAX TECHNOLOGIES CORP Patents: Applications Pending

DYNAVAX TECHNOLOGIES CORP Patent Applications Pending

18 applications still open at the USPTO, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.

  • 2025-04-04: Application 19118726; Invention IMMUNOGENIC COMPOSITIONS AGAINST THE OMICRON VARIANT OF SEVERE ACUTE RESPITORY SYNDROME CORONAVIRUS 2 (SARS-COV-2); Applicant Dynavax Technologies Corporation; Status Docketed New Case - Ready for Examination.
  • 2024-08-15: Application 18838947; Invention IMMUNOGENIC COMPOSITIONS COMPRISING A RECOMBINANT NEURAMINIDASE AND CpG OLIGONUCLEOTIDE ADJUVANT, AND USES THEREOF; Applicant DYNAVAX TECHNOLOGIES CORPORATION; Status Non Final Action Mailed.
  • 2024-07-10: Application PCTUS2024037429; Invention LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND BORRELIA OUTER SURFACE PROTEIN A AND C ANTIGENS; Applicant DYNAVAX TECHNOLOGIES CORPORATION; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
  • 2024-07-10: Application PCTUS2024037379; Invention LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND A BORRELIA OUTER SURFACE PROTEIN A ANTIGEN; Applicant DYNAVAX TECHNOLOGIES CORPORATION; Status RO PROCESSING COMPLETED-PLACED IN STORAGE.
FiledApplicationInventionApplicantStatusPublished asInventor nameInventor countryExaminer
2025-04-0419118726IMMUNOGENIC COMPOSITIONS AGAINST THE OMICRON VARIANT OF SEVERE ACUTE RESPITORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)Dynavax Technologies Corporation
Medigen Vaccine Biologics Corporation
Docketed New Case - Ready for ExaminationUS20260124294A1
Charles CHEN
Tsun-Yung KUO
Chung-Chin WU
Wei-Hsuan TANG
Chia-En LIEN
Yi-Jiun LIN
Taiwan
Taiwan
Taiwan
Taiwan
Taiwan
Taiwan
CENTRAL, DOCKET
2024-08-1518838947IMMUNOGENIC COMPOSITIONS COMPRISING A RECOMBINANT NEURAMINIDASE AND CpG OLIGONUCLEOTIDE ADJUVANT, AND USES THEREOFDYNAVAX TECHNOLOGIES CORPORATION
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Non Final Action MailedUS20250161430A1
Florian KRAMMER
Peter PALESE
Adolfo GARCIA-SASTRE
John D. CAMPBELL
Paula TRAQUINA
Robert L. COFFMAN
United States
United States
United States
United States
United States
United States
BLUMEL, BENJAMIN P
2024-07-10PCTUS2024037429LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND BORRELIA OUTER SURFACE PROTEIN A AND C ANTIGENSDYNAVAX TECHNOLOGIES CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
RICCARDO MANETTI
NICOLAS DELAHAYE
DONG YU
United States
United States
United States
2024-07-10PCTUS2024037379LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND A BORRELIA OUTER SURFACE PROTEIN A ANTIGENDYNAVAX TECHNOLOGIES CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
RICCARDO MANETTI
NICOLAS DELAHAYE
DONG YU
United States
United States
United States
2024-06-2118723407IMMUNOGENICITY OF A CPG-ADJUVANTED HERPES ZOSTER VACCINEDynavax Technologies CorporationNon Final Action MailedUS20250163105A1
Robert S. JANSSEN
United States
SALVOZA, M FRANCO G
2024-04-0818629809ALKYL CHAIN MODIFIED IMIDAZOQUINOLINE TLR7/8 AGONIST COMPOUNDS AND USES THEREOFDynavax Technologies CorporationNon Final Action MailedUS20240368155A1
Stewart D. CHIPMAN
Radwan KIWAN
Melissa A. KACHURA
Robert COFFMAN
United States
United States
United States
United States
SHIAO, REI TSANG
2024-03-0118592811IMMUNOGENIC COMPOSITIONS AND METHODS FOR IMMUNIZATION AGAINST VARIANTS OF SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-COV-2)Dynavax Technologies Corporation
Medigen Vaccine Biologics Corporation
Non Final Action MailedUS20240197862A1
Charles CHEN
Tsun-Yung Kuo
Chung-Chin Wu
Wei-Hsuan Tang
Chia-En Lien
Yi-Jiun Lin
Meei-Yun Lin
Taiwan
Taiwan
Taiwan
Taiwan
Taiwan
Taiwan
Taiwan
FOLEY, SHANON A
2023-09-0763581228LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND BORRELIA OUTER SURFACE PROTEIN A AND C ANTIGENSDynavax Technologies CorporationProvisional Application Expired
Nicolas DELAHAYE
Dong Yu
Riccardo Manetti
United States
United States
Italy
2023-07-1063512874LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND A BORRELIA OUTER SURFACE PROTEIN C ANTIGENDynavax Technologies CorporationProvisional Application Expired
Nicolas DELAHAYE
United States
2023-07-1063512872LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND A BORRELIA OUTER SURFACE PROTEIN A ANTIGENDynavax Technologies CorporationProvisional Application Expired
Nicolas DELAHAYE
Dong Yu
Riccardo Manetti
United States
United States
Italy
2023-07-1063512871LYME DISEASE VACCINES COMPRISING AN ADJUVANT AND BORRELIA OUTER SURFACE PROTEIN A AND C ANTIGENSDynavax Technologies CorporationProvisional Application Expired
Nicolas DELAHAYE
Dong Yu
Riccardo Manetti
United States
United States
Italy
2023-06-1318267083METHOD FOR QUANTIFYING CPG-CONTAINING OLIGONUCLEOTIDES IN COMPOSITIONS COMPRISING ALUMDynavax Technologies CorporationNon Final Action MailedUS20240027434A1
Martin GOHLKE
United States
SITTON, JEHANNE SOUAYA
2022-12-22PCTUS2022082311IMMUNOGENICITY OF A CPG-ADJUVANTED HERPES ZOSTER VACCINEDYNAVAX TECHNOLOGIES CORPORATIONRO PROCESSING COMPLETED-PLACED IN STORAGE
ROBERT S. JANSSEN
United States
2022-03-0163315437IMMUNOGENIC COMPOSITIONS COMPRISING A RECOMBINANT NEURAMINIDASE AND CpG OLIGONUCLEOTIDE ADJUVANT, AND USES THEREOFDYNAVAX TECHNOLOGIES CORPORATION
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
Provisional Application Expired
Florian KRAMMER
Peter PALESE
Adolfo GARCIA-SASTRE
John D. Campbell
Paula Traquina
Robert L. Coffman
United States
United States
United States
United States
United States
United States
2021-12-2363293510IMMUNOGENICITY OF A CPG-ADJUVANTED HERPES ZOSTER VACCINEDynavax Technologies CorporationProvisional Application Expired
Robert S. JANSSEN
United States
2021-12-14PCTUS2021072922METHOD FOR QUANTIFYING CPG-CONTAINING OLIGONUCLEOTIDES IN FORMULATIONS COMPRISING ALUMDYNAVAX TECHNOLOGIES CORPORATIONPCT - International Search Report Mailed to IB
MARTIN GOHLKE
United States
KIM, HARRY CHONG HYUN
2021-03-09PCTUS2021021544SHINGLES VACCINES COMPRISING A TLR9 AGONISTDYNAVAX TECHNOLOGIES CORPORATIONPCT - International Search Report Mailed to IB
JOHN D. CAMPBELL
DAVID NOVACK
ROBERT S. JANSSEN
RANDALL N. HYER
United States
United States
United States
United States
THOMAS, SHANE M
2021-03-01PCTUS2021020318CORONAVIRUS VACCINES COMPRISING A TLR9 AGONISTDYNAVAX TECHNOLOGIES CORPORATIONPCT - International Search Report Mailed to IB
JOHN D. CAMPBELL
DAVID NOVACK
ROBERT S. JANSSEN
United States
United States
United States
YOUNG, LEE W